Valuation (40%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.86 | 18.25 |
| PEG Ratio (TTM) | -0.38 | -0.05 |
| P/S Ratio (TTM) | 4.17 | 0.54 |
| P/B Ratio (TTM) | 0.77 | 1.39 |
| P/FCF Ratio (TTM) | -4.02 | 13.41 |
| Price to 5YR AVG Earnings Ratio | 12.01 | 15.59 |
| Price to 5YR AVG FCF Ratio | -7.40 | 63.17 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.75% | 4.46% |
| ROE (TTM) | 2.58% | 9.84% |
| Net Profit Margin (TTM) | 14.95% | 1.28% |
| ROIC 5YR AVG | -4.18% | 12.15% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 942.19% | -18.39% | 27.71% |
| Revenue | 467.04% | -7.43% | -12.38% |
| Net Income | 908.05% | -18.13% | 28.07% |
| Cash Flow | -305.38% | 438.33% | 146.29% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.81 | 2.01 |
| Quick Ratio (TTM) | 0.99 | 1.20 |
| D/E Ratio (TTM) | 0.37 | 0.52 |
| Interest Coverage (TTM) | -19.07 | 4.52 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 2.03 | 3.95 |
| LTL to 5YR AVG FCF | -3.45 | 18.54 |
| Shares Outstanding Growth 5YR AVG | 0.40% | 0.97% |